Comanthoside B

CAS No. 70938-60-2

Comanthoside B( —— )

Catalog No. M29291 CAS No. 70938-60-2

Comanthoside B is a natural product isolated from the aerial portions of Ruellia tuberosa L with anti-inflammatory and antiseptic activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 81 In Stock
5MG 124 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Comanthoside B
  • Note
    Research use only, not for human use.
  • Brief Description
    Comanthoside B is a natural product isolated from the aerial portions of Ruellia tuberosa L with anti-inflammatory and antiseptic activities.
  • Description
    Comanthoside B is a natural product isolated from the aerial portions of Ruellia tuberosa L with anti-inflammatory and antiseptic activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    70938-60-2
  • Formula Weight
    490.4
  • Molecular Formula
    C23H22O12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(cc1)-c1cc(=O)c2c(O)c(OC)c(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)cc2o1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • FSL 1

    TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-κB. Induces pro-inflammatory cytokines including IL-8, IL-1β, CCL20 and TNF-α in vitro. Synergizes with IFNγ to induce CXCL10 release from melanoma cells.

  • FN075

    FN075 is a small-molecule inhibitor targeting Escherichia coli amyloid biogenesis and biofilm formation.

  • Ceforanide

    Ceforanide is a second-generation cephalosporin antibiotic with bactericidal activity. Ceforanide causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall.